非小细胞肺癌根治术后放射治疗价值的前瞻性研究

被引:3
作者
冯勤富
汪楣
汪良骏
杨宗贻
张汝刚
张大为
殷蔚伯
机构
[1] 中国医学科学院协和医科大学肿瘤医院放疗科
[2] 中国医学科学院协和医科大学
关键词
肺肿瘤; 术后放疗; 手术治疗;
D O I
暂无
中图分类号
学科分类号
摘要
目的 评价术后放疗对根治术后N1与N2 非小细胞肺癌的作用。方法  1982年 2月至 1995年12月收治的 36 6例小于 6 5岁的N1与N2 非小细胞肺癌病例 ,随机分为术后放疗组 (n =184)和单纯手术组 (n= 182 )。结果 术后放疗组和单纯手术组 5年生存率分别为 43 .4%± 5 .1%和 40 .5 %± 4.6 % (P =0 .5 6 ) ,5年无瘤生存率分别为 42 .9%± 5 .2 %和 38.3 %± 4.5 % (P =0 .2 8)。T3 4 N1M0 患者在术后放疗组的 5年生存率和5年无瘤生存率分别为 5 8.1%± 15 .5 %和 6 5 %± 12 % ,单纯手术组则分别为 39.9%± 10 .2 % (P =0 .0 92 )和40 %± 10 % (P =0 .0 5 7)。术后放疗可明显减少胸内复发 (P <0 .0 1)。结论 术后放疗可减少局部复发 ,对总的生存改善不明显 ,但对T3 4 或N1患者有望获得治疗益处
引用
收藏
页码:326 / 329
页数:4
相关论文
共 8 条
[1]  
Postoperative radiation therapy in lung cancer: A controlled trial after resection of curative design. Van Houtte P,Rocmans P,Smets P. International Journal of Radiation Oncology Biology Physics . 1980
[2]  
The role of postoperative radiotherapy in non-small cell lung cancer: a multicentre randomised trial in patients with pathologically staged T1-2, N1-2, M0 disease. Stephens Rj,Girling DJ,Bleehen NM,et al. British Journal of Cancer . 1996
[3]  
Effects of postoperative mediastinal radiation on completely resected stage Ⅱ and stage Ⅲ epidermoid cancer of the lung. Lung Cancer Study Group. The New England Journal of Medicine . 1986
[4]  
Post resection radiation therapy of bronchogenic carcinoma. Lewin A,Lavin P,Malcolm A. International Journal of Radiation Oncology Biology Physics . 1981
[5]  
Site of recurrence in patients with stage Ⅰ and Ⅱ carcinoma of the lung resected for cure. Immerman SC,Vanecko RM,Fry WA,et al. The Annals of Thoracic Surgery . 1981
[6]  
Post-irradiation for T2N0M0 nonsmall cell lung carcinoma: A prospective randomised study. Lafitte JJ,Ribet ME,Provost BM,et al. The Annals of Thoracic Surgery . 1996
[7]  
Postoperative radiotherapy for radically resected N2 non-small cell lung cancer: randomised clinical study 1988-92. Debevec M,Bitnec M,Vidmar S. Lung Cancer . 1996
[8]  
Postoperative radiotherapy in non-smallcell lung cancer: systematic review and Meta-analysis of individual patient data from nine randomised controlled trial. PORT Meta-analysis Trialists Group. The Lancet . 1998